Novartis Adds To NASH Pipeline By Licensing Pliant’s Integrin Inhibitor

 
• By Joseph Haas
  
Two businessmen shaking hands during a meeting in the office, success, dealing, greeting & business partner concepts - soft light.
Novartis has made several deals to add to its NASH pipeline
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business